共 8 条
[1]
Fluoroquinolones as pneumococcal therapy: Closing the barn door before the horse escapes. Tillotson G,Zhao X,Drilica K. The Lancet Infectious Diseases . 2001
[2]
Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomized, double-blind comparison with trovafloxacin. Ball P,Wilson R,Mandell L,et al. Journal of Chemotherapy . 2001
[3]
Guidelines for the management of adults with community-acquired pneumonia. Amer Thorac Society. American Journal of Respiratory and Critical Care Medicine . 2001
[4]
A prospective, randomized,double-blind study treating community-acquired pneumonia in hospitalized patients: gatifloxacin VS ceftriaxone clarithromycin. Forgarty C,Dowell M E,Ellison WT,et al. Journal of Respiratory Diseases . 1999
[5]
Clinician’s Manual on Respiratory Tract Infections and Fluoroquinolones. Read R C,Morrissey I,Ambler J E,et al. . 2000
[6]
A double-blind, randomized study of safety and efficacy treating community acquired pneumonia with once-daily gatifloxacin vs once-daily levofloxacin. Sullivan J G,McElroy A,Honsinger R W. et al. Journal of Respiratory Diseases . 1999
[7]
Relative potential for selection of fluoroquinolone-resistant streptococcus pneumoniae strains by levofloxacin:comparison with ciprofloxacin, sparfloxacin and ofloxacin. Drugeon H B,Juvin M E,Bryskier. Journal of Antimicrobial Chemotherapy . 1999
[8]
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized,double-blind comparison with trovafloxacin. File T M Jr,Schlemmer B,Garau J,et al. Journal of Antimicrobial Chemotherapy . 2001